Vishakha Hooda

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Preventing Hand-Foot Syndrome in Patients With Cancer: A Systematic Review and Network Meta-Analysis.

Preventing Hand-Foot Syndrome in Patients With Cancer: A Systematic Review and Network Meta-Analysis.

Journal: JAMA dermatology
Published: March 04, 2026

NK cell hyperactivation drives macrophage repolarization and limits M2 bias in pemphigus vulgaris.

NK cell hyperactivation drives macrophage repolarization and limits M2 bias in pemphigus vulgaris.

Journal: Frontiers in immunology
Published: December 23, 2025

Prevalence and spectrum of homologous recombination repair mutations in patients with metastatic prostate cancer from India.

Prevalence and spectrum of homologous recombination repair mutations in patients with metastatic prostate cancer from India.

Journal: The oncologist
Published: October 25, 2025

DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study.

DPYD genotyping in patients receiving capecitabine: an exploratory analysis from the D-TORCH study.

Journal: Frontiers in pharmacology
Published: October 25, 2025

Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH study.

Association of serum cyclooxygenase-2 levels with hand-foot syndrome in patients receiving capecitabine: an exploratory analysis of D-TORCH study.

Journal: Ecancermedicalscience
Published: February 19, 2025

Alterations in chemokine receptor-ligand interactions and costimulatory molecules in DC-NK crosstalk: A novel therapeutic approach for pemphigus vulgaris.

Alterations in chemokine receptor-ligand interactions and costimulatory molecules in DC-NK crosstalk: A novel therapeutic approach for pemphigus vulgaris.

Journal: Immunology letters
Published: January 29, 2025

Interactions of NK Cells and Macrophages: From Infections to Cancer Therapeutics.

Interactions of NK Cells and Macrophages: From Infections to Cancer Therapeutics.

Journal: Immunology
Published: August 25, 2024

Augmented IFNγ producing ILC1 and IL 17 producing ILC3 in pemphigus vulgaris: Plausible therapeutic target.

Augmented IFNγ producing ILC1 and IL 17 producing ILC3 in pemphigus vulgaris: Plausible therapeutic target.

Journal: Cellular immunology
Published: May 29, 2024

Distorted frequency and functionality of natural killer cells in pemphigus vulgaris: A potential therapeutic target.

Distorted frequency and functionality of natural killer cells in pemphigus vulgaris: A potential therapeutic target.

Journal: Immunology letters
Published: May 09, 2024

Macrophage inhibitory factor alters the functionality of macrophages and their involvement in disease pathogenesis of active generalized vitiligo patients.

Macrophage inhibitory factor alters the functionality of macrophages and their involvement in disease pathogenesis of active generalized vitiligo patients.

Journal: Cytokine
Published: December 14, 2023
Showing 1-10 of 10

Last Updated: 09/26/2026